yahoo_financeOriginal article
1cBio Received Shareholder Proceeds Upon Closing of BioMarin Pharmaceutical Inc.'s Acquisition of Alesta Therapeutics
Positive
AI Analysis
Summary
1cBio received shareholder proceeds after BioMarin Pharmaceutical closed its acquisition of Alesta Therapeutics. The article does not give deal terms.
Outcome Details
BioMarin closed its acquisition of Alesta Therapeutics; shareholder 1cBio received proceeds
Importance:6/10
Sentiment:
0.40
acquisitionM&Adeal closing
Related Companies
Read the original article
Published by yahoo_finance on October 14, 2026 12:00 PM